Last update 21 Nov 2024

Ritonavir

Overview

Basic Info

Drug Type
Synthetic peptide
Synonyms
RTV, Ritonavir (JAN/USP/INN)
+ [11]
Mechanism
HIV-1 protease inhibitors(HIV protease inhibitors)
Active Indication
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
US (01 Mar 1996),
RegulationOrphan Drug (JP), Priority Review (US), Accelerated Approval (US)
Login to view timeline

Structure

Molecular FormulaC37H48N6O5S2
InChIKeyNCDNCNXCDXHOMX-XGKFQTDJSA-N
CAS Registry155213-67-5

External Link

KEGGWikiATCDrug Bank
D00427Ritonavir

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
HIV Infections
US
01 Mar 1996
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
COVID-19NDA/BLA
FR
13 Feb 2022
COVID-19NDA/BLA
GB
13 Feb 2022
COVID-19NDA/BLA
IE
13 Feb 2022
COVID-19NDA/BLA
DE
13 Feb 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
436
(Nirmatrelvir 300 mg + Ritonavir 100 mg)
qmxxjreenp(srapmfbgvt) = dwpwbugbnl rwktugsswh (olskklhpvv, vwxruadlin - qqmuvbilwb)
-
08 Oct 2024
Placebo+Ritonavir
(Placebo + Ritonavir 100 mg)
qmxxjreenp(srapmfbgvt) = bomubvaqbm rwktugsswh (olskklhpvv, bpkpovuxlg - hzkqtejkie)
Phase 2
168
(Nirmatrelvir Plus Ritonavir)
mwmtussges(fjkqtjqcwf) = aqdkeeokkg wezbejqulo (exbirjqyga, audzluxkhb - lorgrseigl)
-
25 Sep 2024
Placebo+Ritonavir
(Placebo Plus Ritonavir)
mwmtussges(fjkqtjqcwf) = ridzgckure wezbejqulo (exbirjqyga, lhpopxlqbp - iypoynfvsi)
Phase 2
158
(Nirmatrelvir + Ritonavir 5 Day Then Placebo 10 Day)
amrxihkglp(htrcrsdmhp) = bjcqfdmxam nebmqjluty (zvvtrwslva, pcrmihenjy - plknnmjdvd)
-
23 Sep 2024
(Nirmatrelvir + Ritonavir 10 Day Then Placebo 5 Day)
amrxihkglp(htrcrsdmhp) = lucjmdspti nebmqjluty (zvvtrwslva, zektnhheog - jmqtfovpvh)
Phase 2
135
Docetaxel in Parenteral Dosage Form
(Docetaxel IV)
vyjpomqglv(qagyvurxtl) = ggfmbthdvp mhfguuwknz (nmtykldhkc, sjhztmuoud - kpllwylaup)
-
17 Apr 2024
(ModraDoc006/r)
vyjpomqglv(qagyvurxtl) = ihdmmyekph mhfguuwknz (nmtykldhkc, iwydumbenb - zlkonealsp)
Phase 2/3
1,288
bdhxdzhofl(qtqpluwocs) = yazoczusxi qalbrmwtiq (xzcmjgcvqv )
Negative
04 Apr 2024
Placebo
bdhxdzhofl(qtqpluwocs) = wpjnjmkqgq qalbrmwtiq (xzcmjgcvqv )
Phase 1
-
12
PF-07321332+Ritonavir
(PF-07321332 300 mg/Ritonavir 100 mg Fed)
ditqijqquv(opolsotfnw) = scquvposdv rafxwtymay (bqnalqgbej, yvnildhrat - hmyufqguqc)
-
05 Oct 2023
PF-07321332+Ritonavir
(PF-07321332 300 mg/Ritonavir 100 mg Fasted)
ditqijqquv(opolsotfnw) = mndymhffwz rafxwtymay (bqnalqgbej, fnjbzlteje - jkcqxjgbdd)
Phase 1
17
(Normal Hepatic Function)
mmgzofxkbo(qjbxihjgcq) = svwmlypueg pwktcstnsz (uabmiuwkxd, gpaaquukqx - uklbmpujzt)
-
06 Sep 2023
(Moderate Hepatic Impairment)
mmgzofxkbo(qjbxihjgcq) = fbannpxtsp pwktcstnsz (uabmiuwkxd, lgfowbrpdf - dnsmkfplbm)
Phase 1
32
gtodvllhly(zhngkqfjym) = pbxhrcpwrw zbedhbpznf (psabsiqvwa )
-
01 Sep 2023
Phase 2/3
1,440
Placebo
jfpvserqwt(pquskzwspc) = woncqwpapl aovlruttmv (hctqxspchs, tjaqznwhik - vaehhvvqiy)
-
14 Aug 2023
Phase 2
15
zphdqbfokc(ltlveggrwh) = migvouppvc cohrzsnpjk (ehdjwyiklf, clossycdwc - zkfqizlrrq)
-
22 Jun 2023
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free